Cas 1125746-11-3,7,8-difluoro-4-((2-phenyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)quinolin-2(1H)-one

1125746-11-3

Post Buying Request

Basic information

Product Name: 7,8-difluoro-4-((2-phenyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)quinolin-2(1H)-one
Synonyms: 7,8-difluoro-4-((2-phenyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)quinolin-2(1H)-one
CAS NO:1125746-11-3
Molecular Formula:
Molecular Weight: 389.364
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 7,8-difluoro-4-((2-phenyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)quinolin-2(1H)-one(CAS DataBase Reference)
NIST Chemistry Reference: 7,8-difluoro-4-((2-phenyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)quinolin-2(1H)-one(1125746-11-3)
EPA Substance Registry System: 7,8-difluoro-4-((2-phenyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)quinolin-2(1H)-one(1125746-11-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1125746-11-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1125746-11-3 Suppliers

Recommended suppliers

1125746-11-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1125746-11-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,5,7,4 and 6 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1125746-11:
(9*1)+(8*1)+(7*2)+(6*5)+(5*7)+(4*4)+(3*6)+(2*1)+(1*1)=133
133 % 10 = 3
So 1125746-11-3 is a valid CAS Registry Number.

1125746-11-3Upstream product

1125746-11-3Downstream Products

1125746-11-3Relevant academic research and scientific papers

HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS

-

Page/Page column 71, (2009/04/25)

Novel Quinolone derivatives and pharmaceutical compositions, certain of which have been found to inhibit inducible NOS synthase have been discovered, together with methods of synthesizing and using the compounds including methods for the treatment of iNOS-mediated diseases in a patient by administering the compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1125746-11-3